Mariner, LLC Baxter International Inc Transaction History

Mariner, LLC

$55.8 Billion
Q3 2024

A detailed history of Mariner, LLC transactions in Baxter International Inc stock. As of the latest transaction made, Mariner, LLC holds 54,014 shares of BAX stock, worth $1.59 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

54,014

Previous 46,309 16.64%

Holding current value

$1.59 Million

Previous $1.55 Million 32.34%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$32.85 - $40.26 $253,109 - $310,203	7,705 Added 16.64%	54,014 $2.05 Million
Q2 2024 Aug 13, 2024	SELL	$32.87 - $43.55 $208,691 - $276,498	-6,349 Reduced 12.06%	46,309 $1.55 Million
Q1 2024 May 15, 2024	BUY	$37.88 - $43.77 $434,976 - $502,610	11,483 Added 27.89%	52,658 $2.25 Million
Q4 2023 Feb 14, 2024	SELL	$31.71 - $38.95 $253,806 - $311,755	-8,004 Reduced 16.28%	41,175 $1.59 Million
Q3 2023 Nov 13, 2023	SELL	$37.32 - $49.29 $195,295 - $257,934	-5,233 Reduced 9.62%	49,179 $1.86 Million
Q2 2023 Aug 11, 2023	BUY	$39.98 - $47.68 $8,555 - $10,203	214 Added 0.39%	54,412 $2.48 Million
Q1 2023 May 12, 2023	SELL	$37.58 - $52.57 $2.13 Million - $2.98 Million	-56,702 Reduced 51.13%	54,198 $2.2 Million
Q4 2022 Feb 14, 2023	SELL	$49.7 - $57.71 $204,117 - $237,014	-4,107 Reduced 3.57%	110,900 $5.65 Million
Q3 2022 Nov 10, 2022	BUY	$53.86 - $66.8 $508,438 - $630,592	9,440 Added 8.94%	115,007 $6.19 Million
Q2 2022 Aug 15, 2022	BUY	$63.83 - $80.0 $1.12 Million - $1.4 Million	17,498 Added 19.87%	105,567 $6.78 Million
Q1 2022 May 13, 2022	BUY	$76.85 - $89.45 $1.45 Million - $1.68 Million	18,819 Added 27.18%	88,069 $6.83 Million
Q4 2021 Feb 14, 2022	BUY	$74.57 - $87.19 $820,866 - $959,787	11,008 Added 18.9%	69,250 $5.94 Million
Q3 2021 Nov 15, 2021	BUY	$73.77 - $83.61 $630,585 - $714,698	8,548 Added 17.2%	58,242 $4.68 Million
Q2 2021 Aug 24, 2021	BUY	$80.5 - $88.01 $577,346 - $631,207	7,172 Added 16.87%	49,694 $4 Million
Q1 2021 May 07, 2021	BUY	$76.38 - $86.03 $1.25 Million - $1.41 Million	16,354 Added 62.5%	42,522 $3.59 Million
Q4 2020 Feb 16, 2021	BUY	$75.39 - $82.36 $893,597 - $976,213	11,853 Added 82.8%	26,168 $2.1 Million
Q3 2020 Nov 13, 2020	BUY	$78.33 - $90.73 $55,849 - $64,690	713 Added 5.24%	14,315 $1.15 Million
Q2 2020 Aug 14, 2020	BUY	$78.66 - $94.14 $79,603 - $95,269	1,012 Added 8.04%	13,602 $1.17 Million
Q1 2020 May 14, 2020	SELL	$71.57 - $93.3 $48,596 - $63,350	-679 Reduced 5.12%	12,590 $1.02 Million
Q4 2019 Feb 13, 2020	SELL	$76.7 - $88.45 $94,341 - $108,793	-1,230 Reduced 8.48%	13,269 $1.11 Million
Q3 2019 Nov 13, 2019	BUY	$81.4 - $89.78 $253,316 - $279,395	3,112 Added 27.33%	14,499 $1.27 Million
Q2 2019 Aug 14, 2019	BUY	$73.44 - $82.41 $26,879 - $30,162	366 Added 3.32%	11,387 $933,000
Q1 2019 May 15, 2019	SELL	$64.48 - $81.31 $2.16 Million - $2.72 Million	-33,472 Reduced 75.23%	11,021 $896,000
Q4 2018 Feb 13, 2019	BUY	$61.45 - $77.8 $2.26 Million - $2.86 Million	36,771 Added 476.18%	44,493 $2.93 Million
Q3 2018 Nov 14, 2018	BUY	$70.71 - $77.75 $51,618 - $56,757	730 Added 10.44%	7,722 $595,000
Q2 2018 Aug 14, 2018	BUY	$63.43 - $75.41 $90,641 - $107,760	1,429 Added 25.69%	6,992 $516,000
Q1 2018 May 15, 2018	BUY	$62.56 - $72.26 $97,843 - $113,014	1,564 Added 39.11%	5,563 $362,000
Q4 2017 Feb 09, 2018	BUY	$61.45 - $66.05 $45,227 - $48,612	736 Added 22.56%	3,999 $258,000
Q3 2017 Nov 14, 2017	BUY	$59.5 - $64.61 $194,148 - $210,822	3,263	3,263 $205,000

Others Institutions Holding BAX

# of Institutions

1,007

Shares Held

450M

Call Options Held

2.79M

Put Options Held

2.44M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $14.9B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.

Account